Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 4/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL438679 | 1.00 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL438629 | 1.00 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL4799222 | 1.00 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL439209 | 1.00 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL3538819 | 1.00 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL7760007 | 1.00 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL439341 | 1.00 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL10697643 | 0.97 | DNM1 (0.42) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL440059 | 0.90 | CA12 (0.36) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL437872 | 0.88 | FAAH (0.45) | LMNAHSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133057-B2 | Dialkanolamines as additives for grinding solids | SIKA TECHNOLOGY AG (CH) | 2015-09-15 | — | — | US | disclosed |
| EP-1812401-B1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF SE (DE) | 2015-06-24 | — | — | EP | disclosed |
| US-20140150694-A1 | DIALKANOLAMINES AS ADDITIVES FOR GRINDING SOLIDS | SIKA TECHNOLOGY AG (CH) | 2014-06-05 | — | — | US | disclosed |
| WO-2012160210-A1 | DIALKANOLAMINES AS ADDITIVES FOR GRINDING SOLIDS | SIKA TECHNOLOGY AG (CH) | 2012-11-29 | — | — | WO | disclosed |
| US-7799920-B2 | Method for producing perylene-3,4-dicarboxylic acid imides | BASF AKTIENGESELLSCHAFT (DE) | 2010-09-21 | — | — | US | disclosed |
| US-20080114170-A1 | Method For Producing Perylene-3,4-Dicarboxylic Acid Imides | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-15 | — | — | US | disclosed |
| EP-1812401-A1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006050860-A1 | METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080114170-A1 | Method For Producing Perylene-3,4-Dicarboxylic Acid Imides | CPNE4, IDH3A, RPL23A | DNM1 658/4885CA12 324/4885CA1 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.